De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Elsoft Research Berhad Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

Elsoft Research Berhad heeft een totaal eigen vermogen van MYR130.5M en een totale schuld van MYR0.0, wat de schuld-eigenvermogensverhouding op 0% brengt. De totale activa en totale passiva bedragen respectievelijk MYR135.8M en MYR5.4M.

Belangrijke informatie

Verhouding schuld/eigen vermogen

RM 0

Schuld

Rente dekkingsratio	n/a
Contant	RM 89.48m
Aandelen	RM 130.46m
Totaal verplichtingen	RM 5.37m
Totaal activa	RM 135.83m

Recente financiële gezondheidsupdates

Geen updates

Recent updates

These Return Metrics Don't Make Elsoft Research Berhad (KLSE:ELSOFT) Look Too Strong

Aug 06

Elsoft Research Berhad (KLSE:ELSOFT) Has Gifted Shareholders With A Fantastic 107% Total Return On Their Investment

Feb 18

Is Elsoft Research Berhad (KLSE:ELSOFT) Likely To Turn Things Around?

Jan 28

Are Elsoft Research Berhad's (KLSE:ELSOFT) Statutory Earnings A Good Guide To Its Underlying Profitability?

Jan 07

Is Elsoft Research Berhad (KLSE:ELSOFT) Potentially Undervalued?

Dec 20

What You Need To Know About Elsoft Research Berhad's (KLSE:ELSOFT) Investor Composition

Dec 07

Is Elsoft Research Berhad's (KLSE:ELSOFT) Stock On A Downtrend As A Result Of Its Poor Financials?

Nov 24

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( MYR99.0M ) ELSOFT } overtreffen de korte termijn passiva ( MYR4.0M ).

Langlopende schulden: De kortetermijnactiva ELSOFT ( MYR99.0M ) overtreffen de langetermijnschulden ( MYR1.4M ).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: ELSOFT is schuldenvrij.

Schuld verminderen: ELSOFT heeft de afgelopen 5 jaar geen schulden gehad.

Schuldendekking: ELSOFT heeft geen schulden en hoeft daarom niet gedekt te worden door de operationele kasstroom.

Rentedekking: ELSOFT heeft geen schulden, dus de dekking van rentebetalingen is geen probleem.

Elsoft Research Berhad Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Recent updates

Second quarter 2024 earnings released: EPS: RM0.002 (vs RM0.004 in 2Q 2023)

These Return Metrics Don't Make Elsoft Research Berhad (KLSE:ELSOFT) Look Too Strong

Elsoft Research Berhad Announces Retirement of Madam Tan Ai Jiew as Non Independent and Non Executive Director, Effective June 7, 2024

Consensus revenue estimates decrease by 28%

First quarter 2024 earnings released: EPS: RM0.002 (vs RM0.004 in 1Q 2023)

Elsoft Research Berhad, Annual General Meeting, Jun 07, 2024

Upcoming dividend of RM0.01 per share

Price target increased by 7.3% to RM0.59

Final dividend of RM0.01 announced

Full year 2023 earnings released: EPS: RM0.011 (vs RM0.063 in FY 2022)

Consensus revenue estimates fall by 15%

Third quarter 2023 earnings released: EPS: RM0.002 (vs RM0.005 in 3Q 2022)

Upcoming dividend of RM0.01 per share at 3.8% yield

New minor risk - Revenue size

Second quarter 2023 earnings released: EPS: RM0.005 (vs RM0.008 in 2Q 2022)

Elsoft Research Berhad Declares Single Tier First Interim Dividend for the Financial Year Ending 31 December, 2023, Payable on October 06, 2023

Elsoft Research Berhad Appoints PROF TAN SRI DATO' DR CHUAH HEAN TEIK as Independent and Non Executive Director

First quarter 2023 earnings released: EPS: RM0.004 (vs RM0.004 in 1Q 2022)

When Should You Buy Elsoft Research Berhad (KLSE:ELSOFT)?

Upcoming dividend of RM0.02 per share at 3.4% yield

Full year 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Elsoft Research Berhad Announces Single Tier Special Dividend for the Year Ended 31 December 2022, Payable on 14 April 2023

Third quarter 2022 earnings released: EPS: RM0.005 (vs RM0.004 in 3Q 2021)

Insufficient new directors

Elsoft Research Berhad Announces Appointment of Ng Tzeh Chyuan as Chief Financial Officer

Price target decreased to RM0.58

Should You Think About Buying Elsoft Research Berhad (KLSE:ELSOFT) Now?

Upcoming dividend of RM0.01 per share

Consensus forecasts updated

Elsoft Research Berhad Announces Single Tier First Interim Dividend, Payable on October 07, 2022

Second quarter 2022 earnings released: EPS: RM0.008 (vs RM0.003 in 2Q 2021)

Capital Allocation Trends At Elsoft Research Berhad (KLSE:ELSOFT) Aren't Ideal

Elsoft Research Berhad Announces Resignation of Datuk Tan Leh Kiah as Joint Secretary

What Is Elsoft Research Berhad's (KLSE:ELSOFT) Share Price Doing?

Elsoft Research Berhad, Annual General Meeting, Jun 10, 2022

Price target decreased to RM0.73

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Insufficient new directors

Upcoming dividend of RM0.01 per share

Full year 2021 earnings: EPS and revenues miss analyst expectations

Elsoft Research Berhad Announces Second Interim Dividend for the Financial Year Ended December 31, 2021, Payable 15 April 2022

Third quarter 2021 earnings released: EPS RM0.004 (vs RM0.004 in 3Q 2020)

Second quarter 2021 earnings released: EPS RM0.003 (vs RM0.002 in 2Q 2020)

Price target increased to RM1.25

Consensus forecasts updated

Full year 2020 earnings released: EPS RM0.001 (vs RM0.025 in FY 2019)

Revenue and earnings miss expectations

Elsoft Research Berhad (KLSE:ELSOFT) Has Gifted Shareholders With A Fantastic 107% Total Return On Their Investment

Is Elsoft Research Berhad (KLSE:ELSOFT) Likely To Turn Things Around?

New 90-day high: RM0.94

Are Elsoft Research Berhad's (KLSE:ELSOFT) Statutory Earnings A Good Guide To Its Underlying Profitability?

New 90-day high: RM0.70

Is Elsoft Research Berhad (KLSE:ELSOFT) Potentially Undervalued?

What You Need To Know About Elsoft Research Berhad's (KLSE:ELSOFT) Investor Composition

Is Elsoft Research Berhad's (KLSE:ELSOFT) Stock On A Downtrend As A Result Of Its Poor Financials?

Third quarter 2020 earnings released: EPS RM0.004

New 90-day low: RM0.60

First half earnings released

New 90-day high - RM0.79

Analyse van de financiële positie

Schuld/ eigen vermogen geschiedenis en analyse

Balans

Ontdek gezonde bedrijven